Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study by Xu, Jianming, Prof, Shen, Lin, Prof, Zhou, Zhiwei, Prof, Li, Jie, Prof, Bai, Chunmei, Prof, Chi, Yihebali, Prof, Li, Zhiping, Prof, Xu, Nong, Prof, Li, Enxiao, Prof, Liu, Tianshu, Prof, Bai, Yuxian, Prof, Yuan, Ying, Prof, Li, Xingya, Prof, Wang, Xiuwen, Prof, Chen, Jia, Prof, Ying, Jieer, Prof, Yu, Xianjun, Prof, Qin, Shukui, Prof, Yuan, Xianglin, Prof, Zhang, Tao, Prof, Deng, Yanhong, Prof, Xiu, Dianrong, Prof, Cheng, Ying, Prof, Tao, Min, Prof, Jia, Ru, MD, Wang, Wei, MD, Li, Jing, MD, Fan, Songhua, MD, Peng, Mengye, PhD, Su, Weiguo, PhD

Get full text